Overview
Mentions in press and media 18
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 8, 2016 | Term Sheet — Tuesday, November 8 | Et cetera I’m going to take a wild guess that many of you are reading Term Sheet from a long polling line. Here’s a few news items to help you pass the time: Paid Content What you need to know about growing cyberattacks From ExtraHop I thou... |
| Oct 28, 2016 | Healthcare Private Equity Firm Essex Woodlands Closes Fund IX, at $543.1M | Healthcare private equity firm Essex Woodlands closes its latest fund, at $543.1m. According to a regulatory form filed with the SEC, Essex Woodlands Fund IX, L.P., was subscribed by 25 investors. The doc lists Managing Directors Petri Vain... |
| Nov 4, 2013 | Healthcare startup with noninvasive, one-time wet AMD treatment touts two years of success | Anti-VEGF therapy proved to be a major breakthrough in treatment for wet AMD. The drugs could halt the progression of the disease and even recapture some lost vision, Taylor said. But the drugs are a chronic therapy. “The patient should go ... |
| Nov 1, 2013 | OrbiMed closes its largest VC fund, predicts rebound in healthcare investing in 2014 | Looking back 5 to 6 years, healthcare venture capital funds raised $7.8 billion, but last year they only raised $2.5 billion. Silverstein and Carl Gordon, a partner and co-head of global private equity, told MedCity News they anticipate ple... |
| Dec 13, 2011 | IntegenX Secures $40M in Series C Funding | IntegenX Inc., a Pleasanton, CA-based developer of rapid human DNA identification technology and DNA sequencing library preparation systems, has secured $40m in Series C funding. The round was led by new investor Essex Woodlands, with parti... |
| Sep 6, 2011 | BreatheAmerica Closes $22M Series B Equity Financing | BreatheAmerica, a developer and manager of centers for patients suffering from allergies, sinusitis and asthma as well as diseases related to the immune system, has closed a $22m Series B equity investment. The round was led by Essex Woodla... |
| Feb 8, 2010 | Ex-CoreValve CEO Lemaitre launches medical device equity fund | Dan Lemaitre, the former CEO of CoreValve Inc., will head up Essex Woodlands Health Ventures’ new medical device fund, White Pine Medical. Last year Medtronic Inc. (NYSE:MDT) spent about $700 million, plus a possible $150 million more, buyi... |
| Mar 31, 2009 | A large health fund (Essex VIII) closes and a major health investor (Google) emerges | An Essex release said it will “ primarily make growth equity investments in companies with a rapidly expanding revenue base and venture investments in companies with breakthrough technologies.” Those investments will be as large as $75 mill... |
| Mar 25, 2009 | Neovista sees $18M to treat eye disorders | Neovista, a Fremont, Calif.-based biotech company specializing in eye diseases, says it raised $18 million in a fourth round of funding to commercialize its new device. The money came from Accuitive Medical Ventures, Carlyle Group, Essex Wo... |
Reviews 0
FAQ about Essex Woodlands Health Ventures
When was Essex Woodlands Health Ventures founded?
Essex Woodlands Health Ventures was founded in 1985.
What has the press written about Essex Woodlands Health Ventures?
Parsers VC has collected 18 articles mentioning Essex Woodlands Health Ventures, among them “Term Sheet — Tuesday, November 8” (Nov 8, 2016) and “Healthcare Private Equity Firm Essex Woodlands Closes Fund IX, at $543.1M” (Oct 28, 2016).
Is Essex Woodlands Health Ventures still active?
Yes, Essex Woodlands Health Ventures is active; its latest activity on Parsers VC dates from Dec 6, 2016.